{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:11:11Z","timestamp":1762884671161,"version":"3.45.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"DOI":"10.1186\/s12875-025-03063-x","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T12:25:43Z","timestamp":1762777543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GPs\u2019 decision-making behaviour in the prescription of aspirin for primary prevention in elderly individuals: a qualitative study using semistructured interviews in France"],"prefix":"10.1186","volume":"26","author":[{"given":"E.","family":"Charuel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lafanech\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bigeault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Cambon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bedhomme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vorilhon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"3063_CR1","doi-asserted-by":"crossref","unstructured":"Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH et al. 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: A report of the American heart Association\/American college of cardiology joint committee on clinical practice guidelines. Circulation. 2023;148(13):e148.","DOI":"10.1161\/CIR.0000000000001183"},{"key":"3063_CR2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","volume":"392","author":"JM Gaziano","year":"2018","unstructured":"Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB, et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet. 2018;392:1036\u201346.","journal-title":"Lancet"},{"key":"3063_CR3","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","volume":"379","author":"The ASCEND Study Collaborative Group","year":"2018","unstructured":"The ASCEND Study Collaborative Group. Effects of aspirin for primary prevention in persons with diabetes mellitus. N Engl J Med. 2018;379:1529\u201339.","journal-title":"N Engl J Med"},{"key":"3063_CR4","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","volume":"379","author":"JJ McNeil","year":"2018","unstructured":"McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med. 2018;379:1509\u201318.","journal-title":"N Engl J Med"},{"key":"3063_CR5","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1056\/NEJMoa1800722","volume":"379","author":"JJ McNeil","year":"2018","unstructured":"McNeil JJ, Woods RL, Nelson MR, Reid CM, Kirpach B, Wolfe R, et al. Effect of aspirin on disability-free survival in the healthy elderly. N Engl J Med. 2018;379:1499\u2013508.","journal-title":"N Engl J Med"},{"key":"3063_CR6","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227\u2013337.","journal-title":"Eur Heart J"},{"issue":"16","key":"3063_CR7","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1001\/jama.2022.4983","volume":"327","author":"KW Davidson","year":"2022","unstructured":"US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Chelmow D, et al. Aspirin use to prevent cardiovascular disease: US preventive services task force recommendation statement. JAMA. 2022;327:1577.","journal-title":"JAMA"},{"key":"3063_CR8","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9 (ANSM). Recommandations de bonne pratique_Bon usage des antiplaquettaires_Argumentaire. 2012."},{"key":"3063_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106504","volume":"147","author":"F Moriarty","year":"2021","unstructured":"Moriarty F, Barry A, Kenny RA, Fahey T. Aspirin prescribing for cardiovascular disease in middle-aged and older adults in Ireland: findings from the Irish longitudinal study on ageing. Prev Med. 2021;147:106504.","journal-title":"Prev Med"},{"key":"3063_CR10","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/ggi.13984","volume":"20","author":"L Pasina","year":"2020","unstructured":"Pasina L, Novella A, Elli C, Nobili A, Ianes A. Inappropriate use of antiplatelet agents for primary prevention in nursing homes: an Italian multicenter observational study. Geriatr Gerontol Int. 2020;20:828\u201332.","journal-title":"Geriatr Gerontol Int"},{"key":"3063_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.medcli.2019.10.012","volume":"155","author":"S Rodr\u00edguez-Mart\u00edn","year":"2020","unstructured":"Rodr\u00edguez-Mart\u00edn S, Garc\u00eda-Lled\u00f3 A, Gil M, Barreira-Hern\u00e1ndez D, Rodr\u00edguez-Miguel A, De Abajo FJ. Prevalencia de prescripci\u00f3n Del \u00e1cido acetilsalic\u00edlico a dosis Bajas En prevenci\u00f3n primaria En poblaci\u00f3n espa\u00f1ola, evoluci\u00f3n Temporal y factores asociados. Med Clin (Barc). 2020;155:104\u201311.","journal-title":"Med Clin (Barc)"},{"key":"3063_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2021.100256","volume":"8","author":"E Boakye","year":"2021","unstructured":"Boakye E, Uddin SMI, Obisesan OH, Osei AD, Dzaye O, Sharma G, et al. Aspirin for cardiovascular disease prevention among adults in the United States: trends, prevalence, and participant characteristics associated with use. Am J Prev Cardiol. 2021;8:100256.","journal-title":"Am J Prev Cardiol"},{"key":"3063_CR13","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/eurjpc\/zwad092","volume":"30","author":"AMD Kristensen","year":"2023","unstructured":"Kristensen AMD, Pareek M, Kragholm KH, Torp-Pedersen C, McEvoy JW, Prescott EB. Temporal trends in low-dose aspirin therapy for primary prevention of cardiovascular disease in European adults with and without diabetes. Eur J Prev Cardiol. 2023;30:1172\u201381.","journal-title":"Eur J Prev Cardiol"},{"key":"3063_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349\u201357.","journal-title":"Int J Qual Health Care"},{"key":"3063_CR15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.56746\/EXERCER.2021.177.410","volume":"32","author":"D Pouchain","year":"2021","unstructured":"Pouchain D, Le Roux G, Dibao-Dina C, Boussageaon R. Grandeur et d\u00e9cadence de l\u2019aspirine Chez les patients \u00e0 risque cardiovasculaire En prevention primaire. EXE. 2021;32:410\u20134.","journal-title":"EXERCER"},{"key":"3063_CR16","doi-asserted-by":"crossref","unstructured":"Paill\u00e9 P, Delory-Momberger C. (dir.). Analyse par th\u00e9orisation ancr\u00e9e. In: Vocabulaire des histoires de vie et de la recherche biographique. Toulouse: \u00c9ditions \u00c9r\u00e8s; 2019.","DOI":"10.3917\/eres.delor.2019.01.0047"},{"key":"3063_CR17","volume-title":"L\u2019entretien. 2e \u00e9d. refondue, avec Une Nouvelle pr\u00e9sentation","author":"A Blanchet","year":"2010","unstructured":"Blanchet A, Gotman A, de Singly F. L\u2019entretien. 2e \u00e9d. refondue, avec Une Nouvelle pr\u00e9sentation. Paris: A. Colin; 2010."},{"key":"3063_CR18","doi-asserted-by":"publisher","DOI":"10.4324\/9780203793206","volume-title":"The discovery of grounded theory: strategies for qualitative research","author":"BG Glaser","year":"2017","unstructured":"Glaser BG, Strauss AL. The discovery of grounded theory: strategies for qualitative research. London New York: Routledge; 2017."},{"key":"3063_CR19","volume-title":"Initiation \u00e0 La recherche qualitative En Sant\u00e9: Le guide pour r\u00e9ussir Sa th\u00e8se Ou son m\u00e9moire","author":"J-P Lebeau","year":"2021","unstructured":"Lebeau J-P. Initiation \u00e0 La recherche qualitative En Sant\u00e9: Le guide pour r\u00e9ussir Sa th\u00e8se Ou son m\u00e9moire. Puteaux] [Paris: Global m\u00e9dia sant\u00e9 CNGE productions; 2021."},{"key":"3063_CR20","unstructured":"Rat C, Trudej B, Kinouani S, Guineberteau C, Bertrand P, Renard V et al. Encadrement r\u00e8glementaire des recherches En m\u00e9decine g\u00e9n\u00e9rale. EXERCER. 2017;135:327\u201334."},{"issue":"3","key":"3063_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/jama.2018.20578","volume":"321","author":"SL Zheng","year":"2019","unstructured":"Zheng SL, Roddick AJ. Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis. JAMA. 2019;321:277.","journal-title":"JAMA"},{"key":"3063_CR22","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/eurheartj\/ehy813","volume":"40","author":"AN Mahmoud","year":"2019","unstructured":"Mahmoud AN, Gad MM, Elgendy AY, Elgendy IY, Bavry AA. Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials. Eur Heart J. 2019;40:607\u201317.","journal-title":"Eur Heart J"},{"key":"3063_CR23","doi-asserted-by":"publisher","unstructured":"Wolfe R, Broder JC, Zhou Z et al. Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial. Eur Heart J. 2025;ehaf514. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf514.","DOI":"10.1093\/eurheartj\/ehaf514"},{"key":"3063_CR24","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1111\/bcp.13355","volume":"83","author":"I Ardoino","year":"2017","unstructured":"Ardoino I, Rossio R, Di Blanca D, Nobili A, Pasina L, Mannucci PM, et al. Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people. Br J Clin Pharmacol. 2017;83:2528\u201340.","journal-title":"Br J Clin Pharmacol"},{"key":"3063_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1037\/hea0000122","volume":"34","author":"C Bonner","year":"2015","unstructured":"Bonner C, Jansen J, McKinn S, Irwig L, Doust J, Glasziou P, et al. How do general practitioners and patients make decisions about cardiovascular disease risk? Health Psychol. 2015;34:253\u201361.","journal-title":"Health Psychol"},{"key":"3063_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-004812","volume":"4","author":"J Jansen","year":"2014","unstructured":"Jansen J, Bonner C, McKinn S, Irwig L, Glasziou P, Doust J, et al. General practitioners\u2019 use of absolute risk versus individual risk factors in cardiovascular disease prevention: an experimental study. BMJ Open. 2014;4:e004812.","journal-title":"BMJ Open"},{"key":"3063_CR27","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","volume":"45","author":"L Mazzolai","year":"2024","unstructured":"Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, et al. 2024 ESC guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J. 2024;45:3538\u2013700.","journal-title":"Eur Heart J"},{"key":"3063_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-018-0856-9","volume":"19","author":"S Mantelli","year":"2018","unstructured":"Mantelli S, Jungo KT, Rozsnyai Z, Reeve E, Luymes CH, Poortvliet RKE, et al. How general practitioners would deprescribe in frail oldest-old with polypharmacy \u2014 the LESS study. BMC Fam Pract. 2018;19:169.","journal-title":"BMC Fam Pract"},{"key":"3063_CR29","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1161\/CIRCULATIONAHA.119.040205","volume":"140","author":"G Marquis-Gravel","year":"2019","unstructured":"Marquis-Gravel G, Roe MT, Harrington RA, Mu\u00f1oz D, Hernandez AF, Jones WS. Revisiting the role of aspirin for the primary prevention of cardiovascular disease. Circulation. 2019;140:1115\u201324.","journal-title":"Circulation"},{"key":"3063_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.amjcard.2020.11.014","volume":"141","author":"O Dasa","year":"2021","unstructured":"Dasa O, Pepine CJ, Pearson TA. Aspirin in primary prevention: what changed? A critical appraisal of current evidence. Am J Cardiol. 2021;141:38\u201348.","journal-title":"Am J Cardiol"},{"key":"3063_CR31","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","volume":"71","author":"By the 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2023","unstructured":"By the 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American geriatrics society 2023 updated AGS beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71:2052\u201381.","journal-title":"J Am Geriatr Soc"},{"key":"3063_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/jamainternmed.2014.5444","volume":"175","author":"DJ Morgan","year":"2015","unstructured":"Morgan DJ, Wright SM, Dhruva S. Update on medical overuse. JAMA Intern Med. 2015;175:120.","journal-title":"JAMA Intern Med"},{"key":"3063_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-024-02657-1","volume":"25","author":"L Warkentin","year":"2024","unstructured":"Warkentin L, Scherer M, K\u00fchlein T, Pausch F, L\u00fchmann D, Muche-Borowski C, et al. Evaluation of the German living guideline protection against the overuse and underuse of health care \u2013 an online survey among German gps. BMC Prim Care. 2024;25:414.","journal-title":"BMC Prim Care"},{"key":"3063_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-007905","volume":"5","author":"H Luijks","year":"2015","unstructured":"Luijks H, Lucassen P, Van Weel C, Loeffen M, Lagro-Janssen A, Schermer T. How gps value guidelines applied to patients with multimorbidity: a qualitative study. BMJ Open. 2015;5:e007905.","journal-title":"BMJ Open"},{"key":"3063_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-016-0490-3","volume":"17","author":"B Austad","year":"2016","unstructured":"Austad B, Hetlevik I, Mj\u00f8lstad BP, Helvik A-S. Applying clinical guidelines in general practice: a qualitative study of potential complications. BMC Fam Pract. 2016;17:92.","journal-title":"BMC Fam Pract"},{"key":"3063_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170228","volume":"12","author":"J Jansen","year":"2017","unstructured":"Jansen J, McKinn S, Bonner C, Irwig L, Doust J, Glasziou P, et al. General practitioners\u2019 decision making about primary prevention of cardiovascular disease in older adults: a qualitative study. PLoS ONE. 2017;12:e0170228.","journal-title":"PLoS ONE"},{"key":"3063_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006544","volume":"4","author":"K Anderson","year":"2014","unstructured":"Anderson K, Stowasser D, Freeman C, Scott I. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4:e006544.","journal-title":"BMJ Open"},{"key":"3063_CR38","doi-asserted-by":"publisher","first-page":"346","DOI":"10.12788\/jhm.2738","volume":"12","author":"DJ Morgan","year":"2017","unstructured":"Morgan DJ, Leppin AL, Smith CD, Korenstein D. A practical framework for Understanding and reducing medical overuse: conceptualizing overuse through the Patient-Clinician interaction. J Hosp Med. 2017;12:346\u201351.","journal-title":"J Hosp Med"},{"key":"3063_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/AAFO2475","volume":"26","author":"J Reeve","year":"2022","unstructured":"Reeve J, Maden M, Hill R, Turk A, Mahtani K, Wong G, et al. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis. Health Technol Assess. 2022;26:1\u2013148.","journal-title":"Health Technol Assess"},{"key":"3063_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-021-01499-y","volume":"23","author":"A Jhaveri","year":"2021","unstructured":"Jhaveri A, Sibley RA, Spatz ES, Dodson J. Aspirin, statins, and primary prevention: opportunities for shared decision making in the face of uncertainty. Curr Cardiol Rep. 2021;23:67.","journal-title":"Curr Cardiol Rep"},{"key":"3063_CR41","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41569-019-0225-y","volume":"16","author":"C Patrono","year":"2019","unstructured":"Patrono C, Baigent C. Role of aspirin in primary prevention of cardiovascular disease. Nat Rev Cardiol. 2019;16:675\u201386.","journal-title":"Nat Rev Cardiol"},{"key":"3063_CR42","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cjco.2023.08.011","volume":"5","author":"C Laferri\u00e8re","year":"2023","unstructured":"Laferri\u00e8re C, Moazzami C, Belley-C\u00f4t\u00e9 E, Bainey KR, Marquis-Gravel G, Fama A, et al. Aspirin for the primary prevention of vascular ischemic events: an updated systematic review and meta-analysis to support shared decision-making. CJC Open. 2023;5:881\u201390.","journal-title":"CJC Open"},{"key":"3063_CR43","unstructured":"Universit\u00e9, Laval. Mc Master University, McGill University. L\u2019Acide ac\u00e9tylsalicyclique (ASA) pour la pr\u00e9vention primaire des maladies cardiovasculaires. 2012."}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-03063-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-025-03063-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-03063-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:06:12Z","timestamp":1762884372000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-025-03063-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3063"],"URL":"https:\/\/doi.org\/10.1186\/s12875-025-03063-x","relation":{},"ISSN":["2731-4553"],"issn-type":[{"type":"electronic","value":"2731-4553"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were conducted in accordance with the relevant guidelines and regulations. Informed consent was obtained from all the subjects and\/or their legal guardian(s). Given that this study was outside the scope of the Jard\u00e9 Law, since it was not considered research involving a human person and did not involve patients, it did not require ethical approval under French research law. Informed consent was obtained from all participants. Data collection was declared to the CNIL (Commission Nationale de l\u2019Informatique et des Libert\u00e9s) by the University of Clermont Auvergne.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"352"}}